Abstract
G protein-gated inwardly rectifying potassium (GIRK/Kir3) channels mediate the inhibitory effects of many neurotransmitters on excitable cells. Four Girk genes have been identified (Girk1–4). Whereas GIRK4 is associated with the cardiac GIRK channel, Girk4 expression has been detected in a few neuron populations. Here, we used a transgenic mouse expressing enhanced green fluorescent protein (EGFP) under the control of the Girk4 gene promoter to clarify the expression pattern of Girk4 in the brain. Although small subsets of EGFP-positive neurons were evident in some areas, prominent labeling was seen in the hypothalamus. EGFP expression was most pronounced in the ventromedial, paraventricular, and arcuate nuclei, neuron populations implicated in energy homeostasis. Consistent with a contribution of GIRK4-containing channels to energy balance, Girk4 knockout (−/−) mice were predisposed to late-onset obesity. By 9 months, Girk4−/− mice were ≈25% heavier than wild-type controls, a difference attributed to greater body fat. Before the development of overweight, Girk4−/− mice exhibited a tendency toward greater food intake and an increased propensity to work for food in an operant task. Girk4−/− mice also exhibited reduced net energy expenditure, despite displaying elevated resting heart rates and core body temperatures. These data implicate GIRK4-containing channels in signaling crucial to energy homeostasis and body weight.
Keywords: body weight, energy balance, hypothalamus, Kir3
G protein-gated inwardly rectifying K+ (GIRK/Kir3) channels mediate the slow inhibitory effect of neurotransmitters and hormones on excitable cells of the heart and nervous system (1). GIRK channels are gated by the Gβγ subunits of the Gi/o subclass of heterotrimeric G proteins (2) and are homo- and heterotetrameric complexes formed by four related subunits (GIRK1–4) (3, 4). Neuronal GIRK channels are thought to consist of various combinations of GIRK1, GIRK2, and GIRK3 channel subunits (5). In contrast, the cardiac GIRK channel (IKACh) is a heterotetramer consisting of GIRK1 and GIRK4 (4).
Girk4−/− mice exhibit a complete loss of cardiac GIRK channel activity and cardiac deficits including a mild resting tachycardia and blunted reflex bradycardia (6), consistent with the known expression pattern of the Girk4 gene (also known as Kcnj5) (7). By careful comparison of tissue from wild-type and Girk4−/− mice, a small number of neuron populations in the adult mouse were identified that express Girk4 (8). Signal intensity was particularly high in the ventromedial hypothalamus, a region that contains the ventromedial (VMN) and arcuate (ARC) nuclei.
The hypothalamus is central to the regulation of food intake and energy expenditure. Early studies suggested that the ventromedial and lateral hypothalamus functioned as satiety and feeding centers, respectively (9). More recent work has shown that orexin neurons in the lateral hypothalamus and neuropeptide Y (NPY)-positive neurons of the ARC are critical for the initiation of feeding (10). Conversely, the VMN and pro-opiomelanocortin (POMC) neurons in the ARC are key neuronal substrates of satiety and enhanced energy expenditure. Although GIRK channels have been implicated in the postsynaptic inhibition of hypothalamic neurons, the subunit composition(s) of the underlying GIRK channel has not been elucidated (e.g. refs. 11 and 12).
Given its otherwise limited tissue distribution, the expression of the Girk4 gene in the ventromedial hypothalamus suggested that GIRK4-containing channels might make important contributions to energy homeostasis. Accordingly, we sought to clarify the expression pattern of Girk4 in the hypothalamus and to examine the impact of Girk4 ablation on body weight, food intake, and energy expenditure. Our findings indicate that GIRK4-containing ion channels make a significant contribution to signaling pathways charged with maintaining energy homeostasis.
Results
We demonstrated by in situ hybridization that the Girk4 gene is expressed in only a few neuron populations, with conspicuous labeling seen in the ventromedial hypothalamus (8). To validate observation, we acquired a transgenic mouse line [Tg(Kcnj5-EGFP)49Gsat] that expresses EGFP under the control of the Girk4 promoter. Cardiac tissue from transgene-positive animals exhibited robust EGFP expression (Fig. 1 A and B). EGFP was expressed in both atrial and ventricular tissue, with fluorescence notably more intense in the atria. Thus, EGFP expression in Tg(Kcnj5-EGFP)49Gsat mice provides an accurate readout of Girk4 gene expression in the heart (8).
EGFP labeling in brain sections from Tg(Kcnj5-EGFP)49Gsat mice confirmed the limited expression of the Girk4 gene in the CNS. EGFP expression was found in small subsets of cells in defined structures, including the substantia nigra and hippocampus (Fig. 1 C and D), and cerebellum (13). In contrast, EGFP labeling in the hypothalamus was prominent and relatively uniform. EGFP intensity was highest in the VMN, although robust expression was also seen in the paraventricular nucleus (PVN) and posterior aspect of the ARC (Table 1 and Fig. 2). Quantification of the overlap between EGFP and the neuron-specific nuclear marker NeuN revealed that most neurons in the VMN (85%), posterior ARC (78%), and PVN (74%) were EGFP-positive [supporting information (SI) Fig. S1].
Table 1.
Nucleus | Abbreviation | Expression |
---|---|---|
Ventromedial hypothalamic nucleus | VMN | +++++ |
Paraventricular hypothalamic nucleus | ||
anterior parvicellular | PaAP | ++++ |
ventral | PaV | + |
lateral magnocellular | PaLM | ++++ |
medial magnocellular | PaMM | +++ |
dorsal (cap) | PaD | +++ |
posterior | PaPo | ++++ |
sub-paraventricular zone | SPa | +++ |
Arcuate nucleus, lateral | ArcL | ++ |
Arcuate nucleus, dorsal | ArcD | + |
Arcuate nucleus, posterior | ArcP | ++++ |
Anterodorsal preoptic nucleus | ADP | +++ |
Lateroanterior hypothalamic nucleus | LA | +++ |
Supramammillary nucleus | SuMM | +++ |
Supramammillary nucleus, lateral | SUML | +++ |
Dorsal tuberomammillary nucleus | DTM | ++ |
Medial preoptic area | MPA | ++ |
Perifornical nucleus | PeF | ++ |
Periventricular hypothalamic nucleus | Pe | ++ |
Reuniens thalamic nucleus | Re | ++ |
Suprachiasmatic nucleus | SCh | ++ |
Zona incerta | ZI | ++ |
Dorsomedial hypothalamic nucleus | DM | + |
Lateral hypothalamic area | LH | + |
Lateral mammillary nucleus | LM | + |
Medial tuberal nucleus | MTu | + |
Premammillary nucleus, ventral | PMV | + |
Posterior hypothalamic area | PH | + |
Anterior hypothalamic area, central | AHC | + |
Anterior hypothalamic area, posterior | AHP | + |
EGFP expression levels were determined by fluorescence microscopy in coronal sections. Nuclei were identified based upon morphological criteria and published coordinates for the adult mouse. Labeling intensities: +++++, highest; ++++, very strong; +++, strong; ++, moderate; +, weak. Results are based on findings from three transgenic mice. EGFP was not detected in the median eminence (ME), anterior hypothalamic area (anterior, AHA), medial mammillary nucleus (lateral, ML; median, MMn; or medial, MM), mammillothalamic tract (mt), lateral preoptic area (LPO), or fornix (f).
Given the relevance of the VMN, ARC, and PVN to energy homeostasis, we sought to determine whether genetic ablation of Girk4 influenced body weight (Fig. 3). The Girk4−/− mouse line was created by using embryonic stem cells derived from the 129S1/SvImJ inbred strain (14). Before evaluating body weight, the Girk4 null mutation was backcrossed for 22 generations against the C57BL/6J inbred strain. Fine mapping revealed that the Girk4 null allele was flanked by between 3.8 Mbp (30.2–34.0 Mbp) and 5.3 Mbp (29.7–35.0 Mbp) of residual 129/SvImJ sequence, also referred to as the differential chromosome segment (SI Text and Table S1). This region contains 13–19 genes (Table S2). Because 129/SvImJ mice exhibit lower body weights and body fat content than C57BL/6J mice (15), any contribution of the minimal residual 129/SvImJ-based genomic sequence to phenotypic expression would be predicted to favor a lean phenotype.
Body weights of group-housed Girk4−/− mice mirrored those of wild-type controls from 3 weeks to 2 months of age (Fig. 3A). Genotype-dependent differences developed between 3 and 9 months of age, however, such that Girk4−/− mice were ≈25–30% heavier than their wild-type counterparts (Fig. 3 B and C). Interestingly, the coefficient of variation (CV%) linked to body weight was typically 2–4 times larger for Girk4−/− mice as compared with wild-type controls for any given time point, attesting to the large intersubject variability seen in the Girk4−/− group. A general linear mixed model analysis revealed an influence of gender [male > female, t(137) = 4.08; P < 0.001] and genotype [Girk4−/− > wild type, t(137) = 4.81; P < 0.001] on weight gain between 3 and 12 months; the interaction between gender and genotype was not significant. Naso-anal body length measurements were similar for wild-type and Girk4−/− mice (data not shown), suggesting that enhanced linear growth does not explain the overweight phenotype. Chemical (Soxhlet) analysis of body composition revealed significantly higher fat content in Girk4−/− mice at 12 months of age (Fig. 3D).
To determine whether the intersubject variability in body weight among Girk4−/− mice was unique to group-housing conditions, we tracked weight in a cohort of mice weaned into single housing at 8 weeks of age. Although single housing does influence behavior in C57BL/6 mice (16), the impact on body weight and food intake is relatively small (17). At separation, there was an effect of gender [t(145) = 7.81; P < 0.001] but not genotype [t(145) = 0.57; P = 0.57] on body weight. During acclimation (8–12 weeks), weight gain was similar across groups (≈2 g). Consistent with the group-housing study, males gained more weight than females [t(145) = 2.08; P = 0.04] and Girk4−/− mice gained more weight than controls [t(145) = 3.05; P < 0.01] between 12 and 36 weeks (Fig. 4 A and B). Furthermore, the intersubject variability in body weights for male (CV% = 10–19) and female (CV% = 11–24) Girk4−/− mice was larger than that seen for male (CV% = 4–7) and female (CV% = 5–9) wild-type mice. Thus, elevated weight gain and intersubject variability in body weights for Girk4−/− mice are not linked to group housing. Nevertheless, only female Girk4−/− mice were heavier than wild-type counterparts at the end of the study (Fig. 4 A and B). This discrepancy may reflect a tendency toward lower baseline body weights for the cohort of male Girk4−/− mice evaluated in the single-housing study (Fig. 4A) or a unique sensitivity of male Girk4−/− mice to single-housing conditions.
Daily food intake for single-housed wild-type mice was slightly higher during acclimation than seen for the same animals between 13 and 36 weeks (Fig. 4 C and D). Girk4−/− mice, in contrast, showed stable intake values between 8 and 36 weeks. While average daily food intake for single-housed Girk4−/− mice tended to be higher than that of wild-type controls, differences were not observed consistently. A significant effect of genotype on cumulative food intake (12–36 weeks) was observed [Girk4−/− > wild type, t(170) = 2.33; P < 0.05], however, as was an interaction between gender and genotype [t(170) = 2.46; P < 0.05]. Indeed, genotype-dependent differences in cumulative food intake appeared larger for female than male subjects. Interestingly, when cumulative food intake was included in the original general linear mixed model as a covariate, we found that although intake was predictive of baseline body weight (P < 0.001) and weight gain (P < 0.001), the effect of gender and genotype on these parameters remained significant (P value <0.05). Thus, enhanced intake alone is unable to account for the enhanced weight gain seen in Girk4−/− mice during this study.
We also measured the reinforcing effect of food in male wild-type and Girk4−/− mice using a three-phase operant task (18). Animals were subjected to mild food restriction to enhance operant responding; food restriction resulted in ≈5% reduction in free-feeding weight that did not differ between genotypes (data not shown). In phase 1, animals were trained to lever-press for food. The days required to satisfy acquisition criteria did not differ between genotypes (Table 2). Girk4−/− mice did show slightly more active lever responding and pellets earned during phase 1 and phase 2, a transitional phase involving an FR 5 schedule of reinforcement. In phase 3, which involved progressive ratio scheduling (18), Girk4−/− mice displayed significantly elevated responding. Upon return to ad libitum feeding conditions, operant responding of Girk4−/− mice was greater, but not significantly different, than that seen for wild-type mice. Thus, caloric imbalance caused by food restriction influences operant responding in Girk4−/− mice.
Table 2.
Group | Phase 1 (FR1) |
Phase 2 (FR5) |
Phase 3 (PR) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Rate | Lever presses |
Pellets | Lever presses |
Pellets | Restricted |
Ad libitum |
|||||
Active | Inactive | Active | Inactive | Active | Pellets | Active | Pellets | ||||
Wild type | 5.7 ± 0.5 | 92 ± 12 | 9 ± 3 | 63 ± 7 | 289 ± 38 | 13 ± 3 | 50 ± 5 | 738 ± 153 | 16.0 ± 1.0 | 216 ± 64 | 10.1 ± 1.2 |
Girk4−/− | 5.9 ± 0.6 | 112 ± 11 | 8 ± 1 | 74 ± 6 | 325 ± 30 | 14 ± 3 | 58 ± 5 | 1,313 ± 128* | 18.3 ± 0.7 | 366 ± 140 | 11.9 ± 0.9 |
The performance of male wild-type (n = 7) and Girk4−/− (n = 13) mice during acquisition (phase I, FR1), transition (phase 2, FR5), and progressive ratio (phase 3) components of the operant study. Mice were subjected to mild food restriction (3 g/day plus amount earned) during Phases 1, 2, and the food-restricted component of Phase 3. The rate to achieve acquisition (d), number of active and inactive lever presses, and pellets earned were averaged for each subject over the final 3 days of stable responding during Phases 1 and 2, and over the last 2 days of responding for Phase 3. Inactive lever responding did not differ during Phase 3 for wild-type and Girk4−/− mice (not shown).
*, P < 0.05 vs. wild-type.
Decreased energy expenditure could also contribute to the late-onset overweight phenotype seen in Girk4−/− mice. Given the role for GIRK4 in the formation of IKACh, we evaluated heart rate and core body temperature by telemetry in wild-type and Girk4−/− mice at 3, 6, and 9 months of age. Core body temperature was consistently higher in Girk4−/− mice, and significant differences were observed at 3 and 6 months (Fig. 5A). Girk4−/− mice exhibited a resting tachycardia at all time points evaluated (Fig. 5B). Thus, with respect to these endpoints, Girk4−/− mice show evidence of an increase, rather than a decrease, in energy expenditure.
We next measured net energy expenditure in wild-type and Girk4−/− mice using indirect calorimetry. Animals were evaluated at 2–4 months to determine whether genotype-dependent differences in energy expenditure preceded the development of overweight. Spontaneous physical activity was measured together with O2 consumption and CO2 production during a 22.5-h session. No significant differences between genotypes were observed with respect to body weight, body fat, or lean body mass measured before the test session (Table 3). Similarly, food intake and fecal deposits measured during the testing session did not differ between genotypes (data not shown). Although ambulatory and vertical activity was comparable across genotype, females were more active than males during testing.
Table 3.
Parameter | Male |
Female |
Main Effects |
||||
---|---|---|---|---|---|---|---|
Wild-type | Girk4−/− | Wild-type | Girk4−/− | Gender | Genotype | ||
Body mass, g | 27.3 ± 1.5 | 29.1 ± 1.4 | 22.7 ± 0.7‡ | 23.8 ± 0.6‡ | M > F*** | ||
Body fat, g | 3.1 ± 0.3 | 4.4 ± 0.7 | 3.1 ± 0.3 | 3.0 ± 0.3 | |||
Lean body mass, g | 20.8 ± 1.2 | 20.8 ± 0.8 | 16.9 ± 0.5‡ | 18.1 ± 0.5‡ | M > F*** | ||
Ambulation (×1,000) | 41.5 ± 4.9 | 41.8 ± 3.4 | 57.1 ± 4.4‡ | 44.0 ± 3.5† | M < F* | ||
Vertical activity (×1,000) | 3.0 ± 0.7 | 2.6 ± 0.4 | 5.2 ± 0.8‡ | 3.2 ± 0.4† | M < F* | ||
O2 consumption, L | 57.5 ± 1.0 | 63.0 ± 2.3 | 65.5 ± 1.8‡ | 57.1 ± 2.3†‡ | interaction | ||
Light | 25.5 ± 0.9 | 27.8 ± 1.2 | 28.5 ± 1.0 | 24.8 ± 1.0† | interaction | ||
Dark | 32.0 ± 0.3 | 35.2 ± 1.3 | 36.9 ± 1.0‡ | 32.2 ± 1.5† | interaction | ||
CO2 production (L) | 52.8 ± 1.2 | 57.9 ± 1.9 | 58.9 ± 1.6‡ | 52.0 ± 2.3†‡ | interaction | ||
Light | 22.4 ± 1.0 | 24.4 ± 1.1 | 25.0 ± 0.8 | 22.2 ± 1.0† | interaction | ||
Dark | 30.4 ± 0.5 | 33.4 ± 1.0 | 33.9 ± 0.8‡ | 29.9 ± 1.5†‡ | interaction | ||
RER | 0.91 ± 0.01 | 0.92 ± 0.01 | 0.90 ± 0.02 | 0.91 ± 0.02 | |||
Heat, kcal | 7.5 ± 0.3 | 7.1 ± 0.2 | 7.8 ± 0.2 | 7.1 ± 0.4 | |||
Active | 4.0 ± 0.3 | 3.8 ± 0.2 | 4.6 ± 0.2 | 3.8 ± 0.2 | WT > KO* | ||
Light | 1.6 ± 0.2 | 1.4 ± 0.1 | 1.7 ± 0.1 | 1.5 ± 0.2 | |||
Dark | 2.4 ± 0.2 | 2.3 ± 0.1 | 2.9 ± 0.2 | 2.2 ± 0.1† | WT > KO* | ||
Rest | 3.5 ± 0.1 | 3.3 ± 0.2 | 3.2 ± 0.2 | 3.4 ± 0.3 | |||
Normalized heat, kcal/g | 0.37 ± 0.03 | 0.34 ± 0.01 | 0.46 ± 0.02‡ | 0.40 ± 0.02† | M < F** | WT > KO* | |
Active | 0.20 ± 0.03 | 0.18 ± 0.01 | 0.27 ± 0.01‡ | 0.21 ± 0.01† | M < F** | WT > KO* | |
Light | 0.08 ± 0.01 | 0.07 ± 0.01 | 0.10 ± 0.01 | 0.09 ± 0.01 | M < F* | ||
Dark | 0.12 ± 0.01 | 0.11 ± 0.01 | 0.17 ± 0.01‡ | 0.12 ± 0.01† | M < F** | WT > KO** | |
Rest | 0.17 ± 0.01 | 0.16 ± 0.01 | 0.19 ± 0.01 | 0.19 ± 0.02 |
Subjects were evaluated between 12–16 weeks of age (n = 6–8 per genotype and gender). Body weight and composition were determined prior to testing. Activity data are presented as infrared beam breaks. Raw and normalized (to lean body mass) heat (kcal) values are presented. Columns on the right indicate when a main effect of genotype or gender was observed. The nature of the main effect is denoted using the following abbreviations: male (M), female (F), wild-type (WT), and Girk4−/− (KO). *, P < 0.05; **, P < 0.01; ***, P < 0.001. With respect to O2 consumption and CO2 production, no main effect of genotype or gender was observed, though significant genotype x gender interactions were detected (P < 0.01 in all cases). Results of pair-wise comparisons are noted next to the appropriate value in the table: †, P< 0.05 vs. wild-type, same gender; ‡, P < 0.05 vs. male, same genotype. Differences between male and female mice of different genotypes are not reported in this table.
With regard to O2 consumption and CO2 production, interactions between gender and genotype were detected. O2 consumption and CO2 production for Girk4−/− males were consistently (although not significantly) larger than those measured in wild-type males, although Girk4−/− females exhibited smaller values than female wild-type animals. Mean respiratory exchange ratios (RER), however, were equivalent across groups. More importantly, a main effect of genotype on heat production was observed during periods of activity, and specifically in periods of activity during the dark phase. During these periods, wild-type mice expended significantly more energy than Girk4−/− mice. When heat production was normalized to lean body mass, main effects of genotype and gender were evident during the full session. Genotype-dependent differences were attributed primarily to differences observed in periods of activity during the dark phase, when wild-type animals expended more energy than Girk4−/− mice. Thus, despite their elevated core body temperatures and resting heart rates, Girk4−/− mice exhibited reduced overall energy expenditure.
Discussion
Recently, Tordoff and colleagues (19) compiled body-weight information on ≈2,000 viable knockout mouse strains. They discovered that although lean phenotypes are commonly observed in knockout mice (31% of all lines evaluated), only ≈3% of knockout lines weighed more than wild-type controls. Some of these mouse knockout models of obesity manifest massive overweight at an early age, such as mice lacking the melanocortin 4 receptor or leptin receptor (20, 21). Some knockout mice, including mice lacking the tubby candidate gene, develop obesity with age (22). These lines may be particularly helpful as we seek to understand the doubling in prevalence of human obesity between 20 and 50 years of age (23). Here, we report that Girk4−/− mice are predisposed to moderate (25%) late-onset obesity. To the best of our knowledge, this is only the second report of knockout model of obesity involving ion channel ablation. Mice lacking the Kir6.2/Kcnj11 gene, which contributes to formation of the KATP channel, have been shown in one but not another study to evince a mild (10%) overweight phenotype (24, 25).
Girk4−/− mice exhibited significantly lower net energy expenditure than wild-type control mice at 3–4 months of age, before the onset of overweight. As such, reduced energy expenditure should be considered a causative factor in the development of obesity in Girk4−/− mice. It is also noteworthy that Girk4−/− mice exhibited a mild tachycardia and elevated core body temperature between 3 and 9 months of age. Given the known distribution and role of GIRK4 in the heart, it seems reasonable to postulate that the elevated heart rate (and perhaps core body temperature) reflected a loss of IKACh. Because cardiac output contributes to heat production, one would predict that energy expenditure would have been even lower in Girk4−/− mice had cardiac output been normal.
Girk4−/− mice also exhibited slightly elevated food intake relative to wild-type controls and out-performed wild-type counterparts in an operant test involving food. With regard to operant performance, genotype-dependent differences were prominent during progressive ratio scheduling, which is thought to probe the reinforcing efficacy of natural and drug rewards. Girk4 expression has been studied in brain regions linked to reinforcement, including the prefrontal cortex (PFc), nucleus accumbens (NAc), and ventral tegmental area (VTA). Girk4 expression was not detected in the NAc (3, 8). In sections from Tg(Kcnj5-EGFP)49Gsat mice, weak and diffuse EGFP labeling was observed in neuropil of the NAc, VTA, and PFc (data not shown). In the VTA, as was seen in the substantia nigra, a small number of cell bodies were EGFP-positive (data not shown). Thus, GIRK4-containing channels may modulate the excitability of a small fraction of VTA neurons. The VTA and NAc also receive input from the VMN (26, 27). Thus, hypothalamic GIRK4-containing channels may indirectly modulate reward-relevant signaling in the mesocorticolimbic dopamine system.
It is somewhat difficult to reconcile the enhanced motivation to work for food in the operant study with the small (typically insignificant) genotype-dependent differences in daily home-cage food intake. Indeed, genotype-dependent differences were clearly evident in short test sessions (3 h) during the operant study, whereas such differences were difficult to detect in prolonged assessments of home-cage food intake. We speculate that this inconsistency relates to study-dependent differences in food availability and/or composition. Operant performance was assessed under conditions of mild food restriction and involved small palatable food pellets. Thus, genotype-dependent differences related to food size, palatability, and/or food restriction could explain the robust food-maintained operant responding and slightly elevated home-cage food intake seen in single-housed Girk4−/− mice. Future studies exploring operant performance for food of distinct composition, as well as analysis of the physiological responses to food restriction, should clarify this important issue.
Given its otherwise limited tissue distribution, the conspicuous expression of Girk4 in hypothalamic nuclei mediating energy homeostasis suggests an anatomic basis for the observed phenotype. Furthermore, GIRK channels have been implicated in the postsynaptic inhibitory effect of inhibitory transmitters on many hypothalamic neuron subtypes (11, 28, 29). Thus, it is useful to consider the impact of GIRK channel ablation on these neuron populations and energy balance. Inhibition of POMC and VMN neurons, for example, promotes food intake and reduces energy expenditure (9, 30). Loss of GIRK channels in these neurons should, therefore, inhibit food intake and enhance energy expenditure. Conversely, the inhibition of NPY neurons suppresses food intake (e.g. ref. 31). Loss of GIRK channels in this neuron population should, therefore, lead to elevated food intake and reduced energy expenditure. Our observations are more consistent with the latter scenario, but do not preclude roles for GIRK4-containing channels in neuron populations exerting opposing influences on intake and expenditure. As we pursue a detailed understanding of the adult-onset obesity in Girk4−/− mice, we will need to determine the subunit composition(s) of GIRK channels in hypothalamic neurons and discern the electrophysiological consequences of subunit ablation in each neuron type. We also need to consider that the loss of Girk4 in other brain regions or peripheral tissues, including the heart, may be responsible for some or all of the observed adult-onset weight gain.
In summary, we report a significant contribution of GIRK channels to energy homeostasis in mice. Our data specifically implicate the GIRK4 subunit in signaling pertinent to energy expenditure and food intake. Given the restricted expression pattern of the Girk4 gene, pharmacologic and/or genetic strategies aimed at GIRK4-containing channels warrant consideration as approaches to treat or prevent obesity.
Materials and Methods
Animals.
Animal use was approved by the Institutional Animal Care and Use Committee of the University of Minnesota. Unless noted, mice were group-housed (two to four same-sex siblings) on a 12-h light/dark cycle with food and water available ad libitum. The generation of Girk4−/− mice is described in ref. 14. The Girk4 null mutation was backcrossed for 22 generations to the C57BL/6J inbred strain before initiating this study. Litters of wild-type and Girk4−/− mice were generated by crossing wild-type or Girk4−/− parents, which were generated in crosses of Girk4+/− mice. The Tg(Kcnj5-EGFP)49Gsat mouse was obtained from the Mutant Mouse Regional Resource Center.
Histochemistry and Microscopy.
Histochemistry involving brain sections from adult mice (8–10 weeks old) was performed as described in ref. 13. Images were collected by using a Bio-Rad MRC 1024 confocal laserhead on an upright microscope and an Olympus AX-70 camera with Bio-Rad LaserSharp 3.0 software. Adobe Photoshop v.6.0 (Adobe Systems) was used to add color to images.
Longitudinal Studies.
Two cohorts of mice were evaluated. Cohort 1 consisted of group-housed wild-type and Girk4−/− mice fed standard rodent chow (#2018; Harlan Teklad Global Diets) from weaning to 1 year of age. Body weights were measured biweekly from 3 weeks to 3 months of age, and then again at 6, 9, and 12 months. A representative subset of 12-month-old male wild-type and Girk4−/− mice from cohort 1 were killed for analysis of body fat content by Soxhlet extraction, a service provided by Covance Laboratories. Cohort 2 consisted of wild-type and Girk4−/− mice transferred to single-housing at 8 weeks and fed standard rodent chow throughout the study. Body weights and weekly food intake were measured between 12 and 36 weeks. For both studies, body weights were measured between 0800 and 1200 hours during routine cage refreshment.
Operant Performance.
Male wild-type and Girk4−/− mice (8–12 weeks) were evaluated in a three-phase food-maintained operant test using palatable food pellets (20 mg, PJA/100020 dust-free, Noyes Precision Pellets; Research Diets) as described in ref. 18. Body weights were measured before study and were considered to be free-feeding weights.
Telemetry.
Body temperature and heart rate were measured in male wild-type and Girk4−/− mice at 3, 6, and 9 months of age by using implantable radio-transmitters (Data Sciences International) as described in ref. 6. Animals were tested at one time point only. Mice were allowed to recover for 7 d after transmitter-implantation surgery. Heart rates and body temperatures were determined by averaging data obtained over 6 h of recording on day 8 (1000–1600 hours).
Indirect Calorimetry.
Energy expenditure was determined in group-housed mice at 12–16 weeks of age. Experiments were performed with a single-chamber, open-circuit indirect calorimeter (Columbus Instruments) customized to permit the simultaneous measurement of O2 consumption, CO2 production, and activity (32). The chamber (inner dimensions: 4.25 inches × 8 inches × 5 inches; 2-liter volume) and recording equipment were housed in a dedicated room. Calibration of gas sensors was performed for each run with a primary gas standard. Chamber airflow was maintained at 0.6 liter/min, and experiments were performed at 22°C. One day (24 h) before testing, subjects were transferred to a duplicate metabolic chamber for acclimation to the testing environment. Subsequently, mice were transferred to the metabolic chamber connected to oxygen (O2) and carbon dioxide (CO2) sensors for evaluation of energy expenditure. Standard rodent chow and water were available ad libitum during acclimation and testing.
Body composition was determined by using an EchoMRI body composition analyzer (Echo Medical Systems) before and after testing. Body weights were also measured just before and after testing, and changes in body weight or composition, as well as food intake and fecal output, were evaluated during the test session. Sessions began in the middle of the light cycle (1100 h) and continued through the middle of the light cycle on day 2 (1000 h). The first 30 min of data were discarded to minimize the impact of stress on expenditure indices. Every 30 min, a baseline room air measurement was taken, while VO2 and VCO2 were measured during 120 sequential 15-s epochs. The respiratory exchange ratio (RER) was calculated as VCO2/VO2. Heat produced was calculated as described in ref. 32. Ambulatory and vertical counts were tabulated throughout the session. Subjects were considered to have been at rest during a 15-s epoch if there were no ambulatory or vertical counts. Otherwise, subjects were considered to have been active. O2 consumption, CO2 production, and heat production were quantified for the total testing period, during periods of rest or activity, and during light and dark cycles.
Statistical Analysis.
Data are expressed as the mean ± SEM. Statistical analyses were performed with the programs GraphPad Prism v.5.0 (GraphPad Software), StatView v.5.0 (SAS Institute), and SAS PROC MIXED (SAS Institute). The impact of gender and/or genotype on body weight and food intake was evaluated by using a combination of descriptive analysis and linear growth curve models. Operant performance of male wild-type and Girk4−/− mice was compared by using Student's t test. Body composition, energy expenditure, and related indices were compared by two-factor ANOVA, with genotype and gender as independent variables. When significant main effects or interactions were observed, data were then analyzed by using Fisher's PLSD. Significance was set at P < 0.05.
Supplementary Material
Acknowledgments.
We thank Mark Margosian, Maria Jose Cabañero, Maria Roman, Lev Koyrakh, and Lisa Goldberg for excellent technical assistance. This work was supported by National Institutes of Health Grants R01 MH61933 (to K.W.), P50 DA011806 (to K.W.), T32 DA007097 (to C.A.P.), and R01 DK69978 (to J.F.M.); Minnesota Obesity Center Pilot and Feasibility Program Awards 14 and 31 (to K.W. and C.M.K.); Spanish Ministry of Education and Science Grant BFU-2006-01896 (to R.L.); and the Department of Veterans Affairs (C.M.K.).
Footnotes
The authors declare no conflict of interest.
This article contains supporting information online at www.pnas.org/cgi/content/full/0803261105/DCSupplemental.
References
- 1.North A. Drug receptors and the inhibition of nerve cells. Br J Pharmacol. 1989;98:13–28. doi: 10.1111/j.1476-5381.1989.tb16855.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Logothetis DE, Kurachi Y, Galper J, Neer EJ, Clapham DE. The βγ subunits of GTP-binding proteins activate the muscarinic K+ channel in heart. Nature. 1987;325:321–326. doi: 10.1038/325321a0. [DOI] [PubMed] [Google Scholar]
- 3.Karschin C, Dissmann E, Stuhmer W, Karschin A. IRK(1–3) and GIRK(1–4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. J Neurosci. 1996;16:3559–3570. doi: 10.1523/JNEUROSCI.16-11-03559.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Krapivinsky G, et al. The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K+-channel proteins. Nature. 1995;374:135–141. doi: 10.1038/374135a0. [DOI] [PubMed] [Google Scholar]
- 5.Koyrakh L, et al. Molecular and cellular diversity of neuronal G-protein-gated potassium channels. J Neurosci. 2005;25:11468–11478. doi: 10.1523/JNEUROSCI.3484-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Bettahi I, Marker CL, Roman MI, Wickman K. Contribution of the Kir3.1 subunit to the muscarinic-gated atrial potassium channel IKACh. J Biol Chem. 2002;277:48282–48288. doi: 10.1074/jbc.M209599200. [DOI] [PubMed] [Google Scholar]
- 7.Wickman K, Seldin MF, Gendler SJ, Clapham DE. Partial structure, chromosome localization, and expression of the mouse Girk4 gene. Genomics. 1997;40:395–401. doi: 10.1006/geno.1997.4599. [DOI] [PubMed] [Google Scholar]
- 8.Wickman K, Karschin C, Karschin A, Picciotto MR, Clapham DE. Brain localization and behavioral impact of the G-protein-gated K+ channel subunit GIRK4. J Neurosci. 2000;20:5608–5615. doi: 10.1523/JNEUROSCI.20-15-05608.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.King BM. The rise, fall, and resurrection of the ventromedial hypothalamus in the regulation of feeding behavior and body weight. Physiol Behav. 2006;87:221–244. doi: 10.1016/j.physbeh.2005.10.007. [DOI] [PubMed] [Google Scholar]
- 10.Gao Q, Horvath TL. Neuronal control of energy homeostasis. FEBS Lett. 2008;582:132–141. doi: 10.1016/j.febslet.2007.11.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Roseberry AG, Liu H, Jackson AC, Cai X, Friedman JM. Neuropeptide Y-mediated inhibition of proopiomelanocortin neurons in the arcuate nucleus shows enhanced desensitization in ob/ob mice. Neuron. 2004;41:711–722. doi: 10.1016/s0896-6273(04)00074-1. [DOI] [PubMed] [Google Scholar]
- 12.Acuna-Goycolea C, Tamamaki N, Yanagawa Y, Obata K, van den Pol AN. Mechanisms of neuropeptide Y, peptide YY, and pancreatic polypeptide inhibition of identified green fluorescent protein-expressing GABA neurons in the hypothalamic neuroendocrine arcuate nucleus. J Neurosci. 2005;25:7406–7419. doi: 10.1523/JNEUROSCI.1008-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Aguado C, et al. Cell type-specific subunit composition of G-protein-gated potassium channels in the cerebellum. J Neurochem. 2008 doi: 10.1111/j.1471-4159.2007.05153.x. in press. [DOI] [PubMed] [Google Scholar]
- 14.Wickman K, Nemec J, Gendler SJ, Clapham DE. Abnormal heart rate regulation in GIRK4 knockout mice. Neuron. 1998;20:103–114. doi: 10.1016/s0896-6273(00)80438-9. [DOI] [PubMed] [Google Scholar]
- 15.Reed DR, Bachmanov AA, Tordoff MG. Forty mouse strain survey of body composition. Physiol Behav. 2007;91:593–600. doi: 10.1016/j.physbeh.2007.03.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Voikar V, Polus A, Vasar E, Rauvala H. Long-term individual housing in C57BL/6J and DBA/2 mice: Assessment of behavioral consequences. Genes Brain Behav. 2005;4:240–252. doi: 10.1111/j.1601-183X.2004.00106.x. [DOI] [PubMed] [Google Scholar]
- 17.Yamada K, Ohki-Hamazaki H, Wada K. Differential effects of social isolation upon body weight, food consumption, and responsiveness to novel and social environment in bombesin receptor subtype-3 (BRS-3) deficient mice. Physiol Behav. 2000;68:555–561. doi: 10.1016/s0031-9384(99)00214-0. [DOI] [PubMed] [Google Scholar]
- 18.Pravetoni M, Wickman K. Behavioral characterization of mice lacking GIRK/Kir3 channel subunits. Genes Brain Behav. 2008 doi: 10.1111/j.1601-183X.2008.00388.x. in press. [DOI] [PubMed] [Google Scholar]
- 19.Reed DR, Lawler MP, Tordoff MG. Reduced body weight is a common effect of gene knockout in mice. BMC Genet. 2008;9:4. doi: 10.1186/1471-2156-9-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Abdelilah-Seyfried S, et al. A gain-of-function screen for genes that affect the development of the Drosophila adult external sensory organ. Genetics. 2000;155:733–752. doi: 10.1093/genetics/155.2.733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cohen P, et al. Selective deletion of leptin receptor in neurons leads to obesity. J Clin Invest. 2001;108:1113–1121. doi: 10.1172/JCI13914. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Stubdal H, et al. Targeted deletion of the tub mouse obesity gene reveals that tubby is a loss-of-function mutation. Mol Cell Biol. 2000;20:878–882. doi: 10.1128/mcb.20.3.878-882.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Seidell JC, Flegal KM. Assessing obesity: Classification and epidemiology. Br Med Bull. 1997;53:238–252. doi: 10.1093/oxfordjournals.bmb.a011611. [DOI] [PubMed] [Google Scholar]
- 24.Miki T, et al. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci USA. 1998;95:10402–10406. doi: 10.1073/pnas.95.18.10402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Kanezaki Y, et al. KATP channel knockout mice crossbred with transgenic mice expressing a dominant-negative form of human insulin receptor have glucose intolerance but not diabetes. Endocr J. 2004;51:133–144. doi: 10.1507/endocrj.51.133. [DOI] [PubMed] [Google Scholar]
- 26.Saper CB, Swanson LW, Cowan WM. The efferent connections of the ventromedial nucleus of the hypothalamus of the rat. J Comp Neurol. 1976;169:409–442. doi: 10.1002/cne.901690403. [DOI] [PubMed] [Google Scholar]
- 27.Canteras NS, Simerly RB, Swanson LW. Organization of projections from the ventromedial nucleus of the hypothalamus: A Phaseolus vulgaris-leucoagglutinin study in the rat. J Comp Neurol. 1994;348:41–79. doi: 10.1002/cne.903480103. [DOI] [PubMed] [Google Scholar]
- 28.Priestley T. The effect of baclofen and somatostatin on neuronal activity in the rat ventromedial hypothalamic nucleus in vitro. Neuropharmacology. 1992;31:103–109. doi: 10.1016/0028-3908(92)90018-k. [DOI] [PubMed] [Google Scholar]
- 29.Acuna-Goycolea C, van den Pol AN. Peptide YY(3–36) inhibits both anorexigenic proopiomelanocortin and orexigenic neuropeptide Y neurons: Implications for hypothalamic regulation of energy homeostasis. J Neurosci. 2005;25:10510–10519. doi: 10.1523/JNEUROSCI.2552-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Balthasar N. Genetic dissection of neuronal pathways controlling energy homeostasis. Obesity (Silver Spring) 2006;14(Suppl 5):222S–227S. doi: 10.1038/oby.2006.313. [DOI] [PubMed] [Google Scholar]
- 31.Heisler LK, et al. Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron. 2006;51:239–249. doi: 10.1016/j.neuron.2006.06.004. [DOI] [PubMed] [Google Scholar]
- 32.Wang C, Bomberg E, Billington C, Levine A, Kotz CM. Brain-derived neurotrophic factor in the hypothalamic paraventricular nucleus increases energy expenditure by elevating metabolic rate. Am J Physiol. 2007;293:R992–R1002. doi: 10.1152/ajpregu.00516.2006. [DOI] [PubMed] [Google Scholar]
- 33.Halasy K, Somogyi P. Subdivisions in the multiple GABAergic innervation of granule cells in the dentate gyrus of the rat hippocampus. Eur J Neurosci. 1993;5:411–429. doi: 10.1111/j.1460-9568.1993.tb00508.x. [DOI] [PubMed] [Google Scholar]
- 34.Franklin K, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. New York: Academic; 1997. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.